Statistics

Total Visits

Views
Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of KRAS wild-type metastatic colorectal cancer: Final results of a phase II open-label clinical trial94

Select a period of time:

Number of views in the range

Views
Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of KRAS wild-type metastatic colorectal cancer: Final results of a phase II open-label clinical trial27

Views

Views
October 20252
November 20253
December 20256
January 20266
February 20260
March 20264
April 20266
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States9
France6
Brazil3
Mexico2
Argentina2
Ecuador1
Finland1
Nigeria1
Turkey1
Uruguay1
 

Top cities views

Views
San Jose6
Alejandro Korn1
Ankara1
Helsinki1
Ibadan1
Juiz de Fora1
Montevideo1
Nova Iguaçu1
Quito1
Sorocaba1